2-Decarboxy-2-phosphinico prostaglandin derivatives are disclosed. These derivatives comprise a modified .alpha.-chain and an .OMEGA.-chain bonded to a ring structure. The modified .alpha.-chain has a 2-decarboxy-2-phosphinico group. The derivatives can be used to treat a variety of pharmaceutical and cosmetic conditions.